Chimeric Antigen Receptor T-Cells: The Future Is Now

The immune system acting via cancer immune-surveillance is considered a potential target for improving outcomes among some malignancies. The ability to harness immune cells, engineer them and educate them to target cancer cells has changed the paradigm for treating non-Hodgkin’s lymphomas (NHL) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Mchayleh, Wassim, Bedi, Prabhjot, Sehgal, Rajesh, Solh, Melhem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406995/
https://www.ncbi.nlm.nih.gov/pubmed/30736426
http://dx.doi.org/10.3390/jcm8020207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406995/
https://www.ncbi.nlm.nih.gov/pubmed/30736426
http://dx.doi.org/10.3390/jcm8020207

Ejemplares similares